236 results
DEFA14A
KA
Kineta Inc
30 Apr 19
Additional proxy soliciting materials
4:08pm
by Rule14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
PROTEOSTASIS THERAPEUTICS … previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule0-11(a)(2) and identify the filing for which
DEFA14A
KA
Kineta Inc
13 May 19
Additional proxy soliciting materials
8:02am
by Rule14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
PROTEOSTASIS THERAPEUTICS … with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule0-11(a)(2) and identify the filing for which
DEFA14A
KA
Kineta Inc
29 Apr 20
Additional proxy soliciting materials
4:23pm
by Rule14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
PROTEOSTASIS THERAPEUTICS … previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule0-11(a)(2) and identify the filing for which
DEFA14A
yllopfszvph4igmrc 9a
5 Jun 20
Additional proxy soliciting materials
4:05pm
8-K
EX-99.3
f3tin
14 Nov 22
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:37am
DEFA14A
jn3xpm2s5rk b3r8rvi
26 Apr 24
Additional proxy soliciting materials
4:03pm
8-K
dap9az37
20 Jul 22
Regulation FD Disclosure
6:07am
DEFA14A
j8jfog 039hdx
28 Apr 23
Additional proxy soliciting materials
5:08pm